Not familiar with OCM? OCM is a voluntary program for oncologists who treat Medicare patients with nearly all types of cancer. It provides a monthly payment to participating oncologists as well as an opportunity to earn a performance bonus. In this way, the model is designed to make oncology practices more accountable for the total cost of care.
Since OCM was launched back in 2016, the model has had mixed results. For example, one study published in JAMA found that OCM was associated with lower healthcare utilization, which is one of the model’s goals. But the government’s own most recent analysis found that OCM did not decrease utilization, although it did improve quality. It also shifted oncologists to greater use of biosimilars.
As part of our continual review process, we recently updated our Oncology Care Model module and eBrief with the latest statistics on provider participation in OCM and the most recent results, as well as changes related to the COVID-19 crisis.